Off-topic for aiqbench
This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.
Chipscreen Biosciences: NW001 Receives Clinical Trial Approval
36Kr learned that Chipscreen Biosciences announced it recently received a Drug Clinical Trial Approval Notice issued by the National Medical Products Administration. The company's clinical trial application for injectable NW001, developed in cooperation with Chengdu Chipscreen Xinyu Biotechnology Co., Ltd., for the treatment of advanced malignant tumors, has been approved.
Read the full article at 36KrRelated coverage
People might start believing in radical life extension soon
LessWrong · Jul 20, 2026
XtalPi Holdings Limited: XtalPi Holdings Announces 2026 Interim Results
finanznachrichten.de · Aug 19, 2026
Bill Gates Will NOT And CANNOT Inject Us With A Microchip In A Vaccine - Fails Basic Fact Check
science20.com · Aug 20, 2026
EQS - News: Chainwire: INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer Drug Research and Explore New Applications for XPro
finanznachrichten.de · Oct 16, 2026